Caricamento...
Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
BACKGROUND: The adjuvant use of mitotane on adrenocortical carcinoma (ACC) has always been in controversy. We aimed to assess the prognostic benefits of adjuvant mitotane after resection of ACC in patients without distant metastasis. METHODS: The PubMed, WoS, Embase, and Cochrane Library databases w...
Salvato in:
| Pubblicato in: | Biomed Res Int |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6008618/ https://ncbi.nlm.nih.gov/pubmed/29967789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9362108 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|